JIC
RMD icon

Johnson Investment Counsel’s ResMed RMD Stock Holding History

Johnson Investment Counsel’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
2,299
+440
+24% +$91.2K ﹤0.01% 644
2026
Q1 		$417K Buy
1,859
+51
+3% +$12.7K ﹤0.01% 632
2025
Q4 		$436K Sell
1,808
-57
-3% -$14.6K ﹤0.01% 580
2025
Q3 		$511K Buy
1,865
+200
+12% +$54.6K ﹤0.01% 567
2025
Q2 		$430K Buy
1,665
+45
+3% +$10.7K ﹤0.01% 583
2025
Q1 		$363K Hold
1,620
– – ﹤0.01% 598
2024
Q4 		$371K Buy
+1,620
New +$390K ﹤0.01% 594

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Johnson Investment Counsel's RMD Position: Q2 2026 in Review

Johnson Investment Counsel increased its ResMed (RMD) stake by 24% in Q2 2026, buying an estimated $91.2K and bringing the position to 2,299 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Johnson Investment Counsel first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $511K in Q3 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Johnson Investment Counsel held 2,299 shares of ResMed worth $448K as of Q2 2026.
  • Johnson Investment Counsel bought 440 ResMed shares in Q2 2026, an estimated $91.2K.
  • ResMed made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #644 holding.
  • Johnson Investment Counsel first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Johnson Investment Counsel's ResMed position peaked at $511K in Q3 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.